PREVENTION OF CARDIOEMBOLIC STROKE : USE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION

With the aim of quantifying the use of oral anticoagulant (OA) therapy in clinical practice, we surveyed 150 consecutive patients admitted with a diagnosis of atrial fibrillation (AF). Each patient was administered a questionnaire relating to the classic vascular risk factors and to the antithrombotic treatment received at home.